Journals / Molecular Imaging and Radionuclide Therapy / 2013 / Cilt: 22 - Sayı: 2

Ektopik ACTH Sendromu’nda In-111 Oktreotid ve/veya Ga-68 DOTATATE Görüntülemenin Katkısı

The Value of Somatostatin Receptor Imaging with In-111 Octreotide and/or Ga-68 DOTATATE in Localizing Ectopic ACTH Producing Tumors

Pages
49–55
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PET-CT imaging with Ga-68 peptide conjugates is a promising new modality for this indication.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to evaluate the value of somatostatin receptor imaging (SRI) with In-111 octreotide and Ga-68 DOTATATE in localizing ectopic ACTH producing tumors.
📊
Key Findings & Data:Methods: Nineteen patients who had In-111 octreotide somatostatin receptor scintigraphy (SRS) and/or Ga-68 DOTATATE PETCT to localize ectopic ACTH producing tumors between the years 2000 and 2012 were included retrospectively in our study.
💡
Conclusion & Impact:PET-CT imaging with Ga-68 peptide conjugates is a promising new modality for this indication.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to evaluate the value of somatostatin receptor imaging (SRI) with In-111 octreotide and Ga-68 DOTATATE in localizing ectopic ACTH producing tumors. Methods: Nineteen patients who had In-111 octreotide somatostatin receptor scintigraphy (SRS) and/or Ga-68 DOTATATE PETCT to localize ectopic ACTH producing tumors between the years 2000 and 2012 were included retrospectively in our study. The results of SRI were compared with clinical onset, radiological findings and surgical data of the patients. Results: Sixteen In-111 octreotide SRS and five Ga-68 DOTATATE PET-CT were performed in 19 patients. In eight out of 19 patients, ectopic ACTH secretion site could be detected. In five patients, SRS showed pathologic uptake. In four of these patients, surgery revealed pulmonary carcinoid tumors and in one patient pancreatic neuroendocrine tumor. In one patient, Ga-68 DOTATATE PET-CT revealed pathologic uptake in lung nodule which came out to be pulmonary carcinoid tumor. In another patient who had resection of metastases of atypical carcinoid tumor prior to scans, new metastatic foci were detected both with SRS and Ga-68 DOTATATE PET-CT imaging. In one patient, although SRS was negative, CT which was performed three years later showed a lung nodule diagnosed as pulmonary carcinoid tumor. In 11 patients, ectopic ACTH secretion site could not be detected. In 10 of those patients, scintigraphic and radiological imaging did not show any lesions and in one patient, Ga-68 DOTATATE PET-CT was false positive. Conclusion: SRI has a complementary role with radiological imaging in localizing ectopic ACTH secretion sites. PET-CT imaging with Ga-68 peptide conjugates is a promising new modality for this indication.

Özet

Amaç: Çalışmamızda, In-111 oktreotid sintigrafisi ve Ga-68 DOTATATE PET-BT ile yapılan somatostatin reseptör görüntülemenin (SRG) ektopik ACTH sendromu tanısındaki katkısını incelemeyi amaçladık. Yöntemler: Ektopik ACTH salınım odağının saptanması amacıyla bölümümüzde 2000-2012 yılları arasında In-111 oktreotid sintigrafisi ve/veya Ga-68 DOTATATE PET-BT çekimi yapılan 19 hasta retrospektif olarak incelendi. Tüm çekim sonuçları, radyolojik görüntülemeler, histopatolojik bulgular ve klinik takip bilgileri ile birlikte değerlendirildi. Bulgular: Ondokuz hastada 16 In-111 oktreotid sintigrafisi, beş Ga-68 DOTATATE PET-BT çekimi yapılmıştır. Ondokuz hastanın sekizinde ektopik ACTH salgılanan odak saptanmıştır. In-111 oktreotid sintigrafisi pozitif olup opere edilen toplam beş hastanın dördünde pulmoner karsinoid tümör, bir hastada pankreatik nöroendokrin tümör saptanmıştır. Ga-68 DOTATATE PET-BT görüntülemesinde akciğerdeki nodülde tutulum saptanmış ve opere edilmiş olan hastada patoloji sonucu atipik karsinoid tümör olarak raporlanmıştır. Diğer hastada ise atipik karsinoid tümör metastazları çekimlerden önce rezeke edilmiş, yapılan In-111 oktreotid sintigrafisi ve Ga-68 DOTATATE PET-BT görüntülemede ise yaygın metastatik lezyonlar saptanmıştır. Ektopik ACTH salgılanan odağın bulunabildiği son hastada ise In-111 oktreotid sintigrafisi negatif bulunmuş, takiplerde üç yıl sonra çekilen toraks BT’de izlenen nodülün rezeksiyon sonucu pulmoner karsinoid tümör gelmiştir. Onbir hastada ektopik ACTH salgılanan odak bulunamamıştır. Bu hastalardan 10’unda sintigrafik ve radyolojik görüntülemelerde odak saptanmazken, bir hastada ise Ga-68 DOTATATE PET-BT sonucu yalancı pozitif olarak değerlendirilmiştir. Sonuç: Ektopik ACTH salınım odağının tespitinde SRG radyolojik yöntemlerle tamamlayıcı bir role sahiptir. Ga-68 peptid bileşikleri ile yapılan PET-BT, bu konuda umut vaat eden yeni bir modalitedir.

🔖

Cite This Article

ÖZKAN, Z. G., KUYUMCU, S., BALKÖSE, D., ÖZKAN, B., AKSAKAL, N., YILMAZ, E., ŞANLI, Y., TÜRKMEN, C., ARAL, F., ADALET, I. (2013). Ektopik ACTH Sendromu’nda In-111 Oktreotid ve/veya Ga-68 DOTATATE Görüntülemenin Katkısı. Molecular Imaging and Radionuclide Therapy, Cilt: 22 - Sayı: 2, 49–55. https://ajindex.com/articles/295292

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. The adrenocortical hormones. In: Guyton AC, Hall JE (eds). The textbook of medical physiology. Philadelphia, W.B. Saunders Company; 2000;869-883
  2. Tabarin A, Valli N, Chanson P, Bachelot Y, Rohmer V, Bex-Bachellerie V, Catargi B, Roger P, Laurent F. Usefulness of somatostation receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1999;84:1193-1202
  3. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 2005;90:4955-4462
  4. Hernández I, Espinosa-de-los-Monteros AL, Mendoza V, Cheng S, Molina M, Sosa E, Mercado M. Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor. Archives of Medical Research 2006;37:976-980
  5. De Herder WW, Krenning EP, Malchoff CD, Hofland LJ, Reubi JC, Kwekkeboom DJ, Oei HY, Pols HAP, Bruining HA, Nobels FRE, Lamberts SWJ. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing’s syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. The American Journal of Medicine 1994;96:305-312
  6. Torpy DJ, Chen CC, Mullen N, Doppman JL, Carrasquillo JA, Chrousos GP, Nieman LK. Lack of utility of 111In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: followup of 18 patients. J Clin Endocrinol Metab 1999;84:1186-1192
  7. Tsagarakis S, Christoforaki M, Giannopoulou H, Rondogianni F, Housianakou I, Malagari C, Rontogianni D, Bellenis I, Thalassinos N. A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing’s syndrome. J Clin Endocrinol Metab 2003;88:4754-4758
  8. Loli P, Vignati F, Grossrubatscher E, Dalino P, Possa M, Zurleni F, Lomuscio G, Rossetti O, Ravini M, Vanzulli A, Bacchetta C, Galli C, Valente D. Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques. J Clin Endocrinol Metab 2003;88:1029:1035
  9. Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK. The role of [18F]fluorodeoxyglucose positron emission tomography and [111In]-diethylenetriaminepentaactate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropinsecreting tumors causing Cushing’s syndrome. J Clin Endocrinol Metab 2004;89:2214-2221
  10. Isidori AM, Kaltsa